U.S. flag

An official website of the United States government

NM_024589.3(ROGDI):c.695dup (p.Glu233fs) AND Amelocerebrohypohidrotic syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Dec 12, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002890942.3

Allele description [Variation Report for NM_024589.3(ROGDI):c.695dup (p.Glu233fs)]

NM_024589.3(ROGDI):c.695dup (p.Glu233fs)

Gene:
ROGDI:rogdi atypical leucine zipper [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
16p13.3
Genomic location:
Preferred name:
NM_024589.3(ROGDI):c.695dup (p.Glu233fs)
HGVS:
  • NC_000016.10:g.4797939dup
  • NG_032174.1:g.10013dup
  • NM_024589.3:c.695dupMANE SELECT
  • NP_078865.1:p.Glu233Argfs
  • NP_078865.1:p.Glu233fs
  • LRG_455t1:c.694dup
  • LRG_455:g.10013dup
  • LRG_455p1:p.Glu233Argfs
  • NC_000016.9:g.4847938_4847939insA
  • NC_000016.9:g.4847940dup
  • NM_024589.2:c.694dup
  • NR_046480.2:n.702dup
Protein change:
E233fs
Molecular consequence:
  • NM_024589.3:c.695dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NR_046480.2:n.702dup - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Amelocerebrohypohidrotic syndrome (KTZS)
Synonyms:
EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA; Kohlschutter Tonz syndrome; Epilepsy dementia amelogenesis imperfecta; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009185; MedGen: C0406740; Orphanet: 1946; OMIM: 226750

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003248053Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Dec 12, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003248053.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This variant has not been reported in the literature in individuals affected with ROGDI-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change results in a frameshift in the ROGDI gene (p.Glu233Argfs*99). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 55 amino acid(s) of the ROGDI protein and extend the protein by 43 additional amino acid residues.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024